The amniotic membrane market comprises of processed human amniotic membrane used for various medical applications such as ocular surface reconstruction, wound healing and others. Amniotic membrane has gained significant traction over conventional substitute products due to its anti-inflammatory, anti-fibrotic, anti-microbial and anti-angiogenic properties that aid tissue repair and regeneration. It derived its unique bioactive properties from the presence of growth factors and cytokines which make it an ideal biological scaffold for healing wounds. Additionally, lack of immunohistocompatibility makes amniotic membrane suitable for allografts.

The global amniotic membrane market is estimated to be valued at US$ 3.62 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period from 2023 to 2030.

Key Takeaways

Key players operating in the amniotic membrane market are Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical. The amniotic membrane possesses significant potential in ocular surface reconstruction, wound healing, surgical adjuvants and others. AmnioGraft by MiMedx received FDA approval for use as a surgical barrier in 2018 thus augmenting demand.

Global expansion in the form of collaborations, partnerships and mergers and acquisitions is helping companies strengthen their market presence. For instance, in 2021, Organogenesis acquired Integra's advanced wound care business portfolio to broaden its product offerings. Katena invested in India based Skye Biologics to expand distribution of amniotic membrane in Asia Pacific.

Market drivers: Rising prevalence of ophthalmic and non-healing wounds worldwide coupled with favorable reimbursement policies for amniotic membrane based therapies in developed nations are key drivers. Limitations of conventional treatment options further boosts adoption.

Market restrain: High costs associated with tissue processing, storage and distribution poses major challenges. Stringent regulatory environment and lack of standardization impedes overall market growth.


Segment Analysis
The dehydrated amniotic membrane segment dominates the market currently and is expected to continue its dominance during the forecast period. This is because dehydrated amniotic membrane can be stored for long durations and used as and when required. They are easier to handle and transport as compared to cryopreserved amniotic membranes.

Global Analysis
North America is expected to be the fastest growing region in the global amniotic membrane market during the forecast period. This is attributed to the availability of advanced technologies, rising research & development initiatives, growing incidence of trauma cases and burns, and increasing awareness regarding amniotic membrane products in the region. Additionally, favorable reimbursement policies and strong presence of key players in the region also contributes to the dominant share of North America. Asia Pacific is also estimated to witness significant growth rate owing to increasing healthcare expenditure, rising medical tourism, growing focus of key players on emerging economies and greater acceptance of novel technologies in the region.

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.

 

(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/